The synthesis and structure-activity relationship studies of isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors are discussed. The pharmacokinetic profile of 10 and 21 with adequate CNS penetration, required for in vivo Parkinson's disease models, are disclosed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2012.03.025 | DOI Listing |
Publication Analysis
Top Keywords
isothiazole isoxazole
8
isoxazole fused
8
fused pyrimidones
8
pyrimidones pde7
8
pde7 inhibitors
8
inhibitors sar
4
sar pharmacokinetic
4
pharmacokinetic evaluation
4
evaluation synthesis
4
synthesis structure-activity
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!